Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 86

Results For "Inc"

7922 News Found

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies
News | April 22, 2026

Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies

It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.


Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
Clinical Trials | April 22, 2026

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev


Zyax Chem takes 26% stake in Gaymed Labs
News | April 22, 2026

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push


Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0
Public Health | April 22, 2026

Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0

Policy symposium in Hyderabad focuses on life skills education and community?driven solutions


Blueneem Medical Devices  appoints Manoj Tumkur Venkatachala as Chief Product Officer
People | April 22, 2026

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering


Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks
Hospitals | April 22, 2026

Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks

The programme integrates simulation-based training, expert-led sessions, and case-based discussions


Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


Moderna launches late-stage trial of mRNA bird flu vaccine
Clinical Trials | April 22, 2026

Moderna launches late-stage trial of mRNA bird flu vaccine

The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone


Moderna wins EU approval for first combined flu & COVID shot for adults 50+
Drug Approval | April 22, 2026

Moderna wins EU approval for first combined flu & COVID shot for adults 50+

The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states